Oxford, MS 4/1/2011 (Penny PayDay) -- Allezoe Medical Holdings (OTC:ALZM) yesterday announced, in a press release, that it has recently received information from a number of sources regarding an apparent stock promotion program promoting its common stock, that has been initiated and is being maintained by unrelated parties without the involvement, knowledge, consent, or participation of the Company. As I write, shares of Allezoe Medical were down 4 percent at $2.03 per share on heavy volume of 8.14 million shares compared to its average daily volume of 5.2 million shares. The company has a market cap of $107 million and a 52-week range between $1.28 and $2.60 per share.Part of the promotion appears to be based on a written "advertisement" being distributed to potential market investors which contains multiple outrageous and unfounded claims and assertions regarding Allezoe Medical Holdings and its subsidiary, Organ Transport Services, Inc. The advertisement also claims that all of the statements made regarding Allezoe have been "approved for public dissemination" by Solstice Capital, Inc., and that Solstice Capital, Inc. paid for the advertisement "to provide public awareness for ALZM".
For the record, neither Allezoe nor Organ Transport Systems, or any officer, director, employee or agent of either, has authorized, paid for, or approved this advertisement, has never had any contact or dealings of any kind, directly or indirectly, with Solstice Capital, Inc. or anyone involved with the preparation or distribution of this advertisement, and expressly repudiates the advertisement in its entirety. Investors, shareholders and the investing public are cautioned about purchasing stock in Allezoe Medical Holdings based on this advertisement or any related sales efforts by unrelated third parties. The Company itself is not currently offering or selling any common stock publicly and has not authorized or paid for any person or entity to act on its behalf in connection with any sales or promotional efforts related to its common stock. Any information regarding the Company which is authorized and approved for public distribution will be issued by the Company itself as a press release or public filing with the SEC.
Michael Holder, President and CEO of Allezoe Medical Holdings, stated: "It is unfortunate that both the investing public and a small public company such as Allezoe have become targets of what appears to be a promotional stock scheme based on misrepresentations and exaggerations about the Company. We have already had contact with regulatory authorities regarding this matter and have advised that the Company is not part of the promotion, did not authorize it, did not pay for it, did not approve any promotional materials, and believes the advertisement is materially false and misleading. We have also confirmed that, to the Company's knowledge, no officer, director, employee, or consultant of the Company has offered or sold any of its or their shares in this promotion. In any case, none of the shares issued recently as part of the acquisition of OTS by Allezoe are free trading and will not be able to trade for many months."
No comments:
Post a Comment